Skip to main content
. 2021 Jun 9;3(3):otab026. doi: 10.1093/crocol/otab026

Table 4.

Abnormal surveillance testing for tuberculosis of non-IBD and IBD patients on biologic therapy

Non-IBD (n = 41) IBD (n = 147) Overall (n = 188)
Had at least 1 follow-up surveillance test 14 (67.7) 102 (84.3) 116 (81.7)
Results of TB test during surveillance, n (%)
 Abnormal 2 (4.9) 5 (3.4) 7 (3.7)
 Negative 28 (68.3) 126 (85.7) 154 (81.9)

IBD, inflammatory bowel disease; TB, tuberculosis.